Deanna J. Attai, MD, assistant clinical professor, Department of Surgery, UCLA, discusses a 5-year follow up of patients receiving accelerated partial breast irradiation (APBI) using strut-based applicators.

In this trial, patients were treated with APBI and followed over time. After a median follow up of 5 years, data showed that local recurrence rates and cosmetic outcomes were excellent. Results were comparable to other studies of partial breast irradiation.

This 5-year data supports the use of partial breast irradiation, Attai says, especially with a strut-based applicator.

OncLive TV

® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers. 

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Deanna J. Attai, MD, discusses a 5-year follow up of patients receiving accelerated partial breast irradiation (APBI) using strut-based applicators.

Dr. Attai Discusses 5-Year Outcomes for APBI With Strut-Based Brachytherapy